UBS Group AG - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 149 filers reported holding WUXI PHARMATECH CAYMAN INC in Q1 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$1,527,000
-2.2%
35,326
-4.5%
0.00%0.0%
Q2 2015$1,562,000
-41.7%
36,972
-46.5%
0.00%
-50.0%
Q1 2015$2,681,000
+18.8%
69,138
+3.1%
0.00%0.0%
Q4 2014$2,257,00067,0550.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q1 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders